Emerging Therapeutics in the Treatment of Substance Use Disorders: A Focus on GLP-1 Receptor Agonists, D3R Antagonists, and CRF Antagonists

The prevalence and rising use of alcohol, opioids, and stimulants have led to substance use disorders (SUDs) that are a significant public health challenge. Traditional treatments offer some benefit; however, they often limited by efficacy, side effects, and accessibility, highlighting the urgent ne...

Full description

Saved in:
Bibliographic Details
Main Authors: Khaled Draghmeh, Brian Fuehrlein
Format: Article
Language:English
Published: IMR Press 2025-04-01
Series:Journal of Integrative Neuroscience
Subjects:
Online Access:https://www.imrpress.com/journal/JIN/24/4/10.31083/JIN26361
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items